&Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Buy
2,724
+674
+33% +$179K 0.01% 1240
2026
Q1
$224K Sell
2,050
-1,925
-48% -$274K ﹤0.01% 2177
2025
Q4
$661K Sell
3,975
-20
-0.5% -$3.35K ﹤0.01% 1466
2025
Q3
$783K Buy
3,995
+509
+15% +$83.7K 0.01% 1205
2025
Q2
$313K Buy
+3,486
New +$275K ﹤0.01% 1597
2025
Q1
Sell
-2,332
Closed -$339K 1810
2024
Q4
$339K Buy
+2,332
New +$219K ﹤0.01% 1273

Other funds holding ALAB

&Partners's ALAB Position: Q2 2026 in Review

&Partners increased its Astera Labs (ALAB) stake by 33% in Q2 2026, buying an estimated $179K and bringing the position to 2,724 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #1240.

&Partners first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • &Partners held 2,724 shares of Astera Labs worth $1.36M as of Q2 2026.
  • &Partners bought 674 Astera Labs shares in Q2 2026, an estimated $179K.
  • Astera Labs made up 0.01% of &Partners's portfolio in Q2 2026, its #1240 holding.
  • &Partners first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.